$2.05
0.06[3.02%]
At close: Apr 19
$2.05
0[0.00%]
PreMarket: 9:08AM EDT
Eledon Pharma
(NASDAQ:ELDN)Eledon Pharma Stock (NASDAQ:ELDN), Analyst Ratings, Price Targets, Predictions
Eledon Pharmaceuticals Inc has a consensus price target of $14.5, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on March 22, 2024, November 13, 2023, and October 24, 2023. With an average price target of $13 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 534.15% upside for Eledon Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Noble Capital Markets
Cantor Fitzgerald
SVB Leerink
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Eledon Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/22/2024 | ELDN | Buy Now | Eledon Pharma | $2.05 | 534.15% | HC Wainwright & Co. | Vernon Bernardino | → $13 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2023 | ELDN | Buy Now | Eledon Pharma | $2.05 | 534.15% | HC Wainwright & Co. | Vernon Bernardino | → $13 | Reiterates | Buy → Buy | Get Alert |
| 10/24/2023 | ELDN | Buy Now | Eledon Pharma | $2.05 | 534.15% | HC Wainwright & Co. | Vernon Bernardino | $25 → $13 | Maintains | Buy | Get Alert |
| 09/27/2023 | ELDN | Buy Now | Eledon Pharma | $2.05 | 387.8% | Noble Capital Markets | Robert LeBoyer | → $10 | Initiates | → Outperform | Get Alert |
| 08/22/2023 | ELDN | Buy Now | Eledon Pharma | $2.05 | 339.02% | Cantor Fitzgerald | Alethia Young | → $9 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | ELDN | Buy Now | Eledon Pharma | $2.05 | 1119.51% | HC Wainwright & Co. | Vernon Bernardino | → $25 | Reiterates | Buy → Buy | Get Alert |
| 06/01/2022 | ELDN | Buy Now | Eledon Pharma | $2.05 | 1168.29% | SVB Leerink | Thomas Smith | $33 → $26 | Maintains | Outperform | Get Alert |
| 11/24/2021 | ELDN | Buy Now | Eledon Pharmaceuticals | $2.05 | 1119.51% | HC Wainwright & Co. | Vernon Bernardino | — | Maintains | Buy | Get Alert |
| 04/27/2021 | ELDN | Buy Now | Eledon Pharmaceuticals | $2.05 | 1509.76% | SVB Leerink | Thomas Smith | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Eledon Pharma (ELDN)?
The latest price target for Eledon Pharma (NASDAQ: ELDN) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $13.00 expecting ELDN to rise to within 12 months (a possible 534.15% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eledon Pharma (ELDN)?
The latest analyst rating for Eledon Pharma (NASDAQ: ELDN) was provided by HC Wainwright & Co., and Eledon Pharma reiterated their buy rating.
When was the last upgrade for Eledon Pharma (ELDN)?
There is no last upgrade for Eledon Pharma.
When was the last downgrade for Eledon Pharma (ELDN)?
There is no last downgrade for Eledon Pharma.
When is the next analyst rating going to be posted or updated for Eledon Pharma (ELDN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eledon Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eledon Pharma was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.
Is the Analyst Rating Eledon Pharma (ELDN) correct?
While ratings are subjective and will change, the latest Eledon Pharma (ELDN) rating was a reiterated with a price target of $0.00 to $13.00. The current price Eledon Pharma (ELDN) is trading at is $2.05, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.